ARCHIVES

MET Inhibitor Improved Time To Progression by 56 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Two Sarcoma Drugs Pose Classic Question: How Much PFS Does it Take to Get a Nod?

March 30, 2012

Sen. Brown Introduces Bill on Clinical Trials Coverage

April 3, 2009

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building.

May 12, 2006

June Panel Meeting Dropped

June 3, 1977

CTEP Starts New Effort to Bring Minorities Into Clinical Trials

March 2, 1990